HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer J Thomas Selected Research

Anorexia Nervosa

7/2023Identification of State Markers in Anorexia Nervosa: Replication and Extension of Inflammation Associated Biomarkers Using Multiplex Profiling in Anorexia Nervosa and Atypical Anorexia Nervosa.
1/2023Association Between Ghrelin and Body Weight Trajectory in Individuals With Anorexia Nervosa.
1/2021Ghrelin and PYY in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls.
1/2020Changes in appetite-regulating hormones following food intake are associated with changes in reported appetite and a measure of hedonic eating in girls and young women with anorexia nervosa.
1/2020Developmental stage-dependent relationships between ghrelin levels and hippocampal white matter connections in low-weight anorexia nervosa and atypical anorexia nervosa.
10/2019Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa.
1/2019Radcliffe ARFID Workgroup: Toward operationalization of research diagnostic criteria and directions for the field.
11/2017Low oxytocin levels are related to alexithymia in anorexia nervosa.
2/2017Recovery From Anorexia Nervosa and Bulimia Nervosa at 22-Year Follow-Up.
11/2016Low Fasting Oxytocin Levels Are Associated With Psychopathology in Anorexia Nervosa in Partial Recovery.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer J Thomas Research Topics

Disease

15Anorexia Nervosa
07/2023 - 12/2013
10Avoidant Restrictive Food Intake Disorder
03/2024 - 11/2018
10Feeding and Eating Disorders (Eating Disorder)
10/2023 - 03/2015
4Body Weight (Weight, Body)
07/2023 - 10/2019
4Body Dysmorphic Disorders (Body Dysmorphic Disorder)
10/2020 - 12/2013
3Weight Gain
01/2023 - 11/2017
3Vomiting
01/2020 - 01/2018
3Weight Loss (Weight Reduction)
01/2020 - 03/2015
2Heart Failure
10/2023 - 04/2023
2Bulimia (Binge Eating)
01/2020 - 01/2020
1Inflammation (Inflammations)
07/2023
1Body-Weight Trajectory
01/2023
1Medically Unexplained Symptoms
01/2023
1Malnutrition (Nutritional Deficiencies)
01/2019
1Bulimia Nervosa
02/2017
1Pica (Geophagia)
03/2015
1Thinness
12/2013

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
07/2023 - 01/2020
5GhrelinIBA
01/2023 - 01/2020
4Oxytocin (Pitocin)FDA LinkGeneric
08/2023 - 11/2016
47,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
10/2020 - 12/2013
2myosin-binding protein CIBA
10/2023 - 04/2023
2Myosins (Myosin)IBA
10/2023 - 04/2023
2Proteins (Proteins, Gene)FDA Link
07/2023 - 08/2019
2Peptide YYIBA
07/2023 - 01/2020
2LaxativesIBA
01/2020 - 01/2020
2Dexfenfluramine (Redux)IBA
08/2015 - 11/2014
1Biomarkers (Surrogate Marker)IBA
07/2023
1Cholecystokinin (Pancreozymin)IBA
11/2022
1pyroglutamyl-histidyl-glycineIBA
01/2021
1P-2 (P 2)IBA
01/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020
1Estrogens (Estrogen)FDA Link
10/2019
1CarbohydratesIBA
08/2019
1VitaminsIBA
08/2019
1SugarsIBA
08/2019
1DiureticsIBA
01/2018
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2017
11- (diethylaminopropyl)- 4- phenylpiperazineIBA
11/2017
1PlasticsIBA
03/2015

Therapy/Procedure

2Diet Therapy (Therapy, Diet)
11/2022 - 01/2019
2Enteral Nutrition (Feeding, Tube)
01/2019 - 11/2018
1Occupational Therapy (Therapy, Occupational)
03/2024
1Therapeutics
10/2023
1Transjugular Intrahepatic Portasystemic Shunt
01/2020
1Drug Therapy (Chemotherapy)
11/2018
1Cognitive Training
11/2018
1Palliative Care (Palliative Therapy)
02/2017